Part 2: Managing Opioid Use Disorder in the Hospital Setting
Date & Time:
Tuesday, January 14, 2020
6:00pm - 6:30pm Registration and Dinner
6:30pm - 7:15pm Part 1 Presentation (no CPE)
7:15pm - 7:30pm Break
7:30pm - 8:30pm Part 2 Presentation (CPE)
Location:
Presented By:
Part 1: IL-6R Inhibition in Rheumatoid Arthritis: The KEVZARA Story
Speaker:
Arthur M. Mandelin II, MD/PhD, RMSK, RhMSUS
Associate Professor of Medicine
Northwestern University
Feinberg School of Medicine
Department of Medicine, Division of Rheumatology
Part 1 is sponsored by Sanofi Genzyme and is not eligible for CPE credit.
In accordance with the PhRMA Code on interactions with Healthcare Professionals, attendance at this educational program is limited to healthcare professionals. As such, attendance by guests or spouses is not permitted.
By accepting any food and/or refreshments at this program, you represent that neither your employer nor the particular state(s) in which you are licensed impose restrictions that preclude you from accepting these items. This invitation is non-transferrable.
Part 2: Managing Opioid Use Disorder in the Hospital Setting
Speaker:
Andrew Merker, Pharm.D., BCPS, BCIDP, AAHIVP
Assistant Professor of Pharmacy Practice
Midwestern University Chicago College of Pharmacy
Downers Grove, IL
Part 2 is accredited for pharmacists and pharmacy technicians | 1.0 contact hour (0.1 CEU)This is an independent program provided by ICHP.
Registration:
Register online below. Registration deadline is Friday, January 10, 2020 at 12:00 noon.
This program is free to ICHP members. However, those who do not attend and do not cancel at least 48 hours prior to the program will be charged $50 to cover expenses. Pre-registration is required. Please bring a copy of your email registration confirmation with you to the meeting.
Seating is limited. Student seating will limited to the first 5 students. Student registration is now closed.
Learning Objectives for Pharmacists:
1. Recognize symptoms of opioid withdrawal.
2. Identify inpatient and outpatient interventions that can assist in managing opioid use disorder.
3. Identify an opioid agonist for inpatient administration based on patient specific factors.
Learning Objectives for Pharmacy Technicians:
1. Recognize the symptoms of opioid withdrawal.
2. Identify risk factors for experiencing opioid related toxicity.
3. Describe the role of naloxone dispensing and how patients can obtain.
Accreditation:
The Illinois Council of Health System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 contact hour (0.1 CEU) of continuing pharmacy education credit. ACPE Universal Activity Number
0121-0000-20-005-L08-P & 0121-0000-20-005-L08-T. Type of Activity: Knowledge-based
Attendees must complete a program evaluation and CPE submission online at
www.CESally.com. After successful CPE submission to CPE Monitor, attendees may print their statements of continuing pharmacy education credit at
NABP.pharmacy.
Target Audience: This activity was developed for Health-System Pharmacists and Pharmacy Technicians
Faculty Disclosure: It is the policy of ICHP to ensure balance, independence, objectivity, and scientific rigor in all of its education programs. In accordance with this policy, faculty must disclose to the participants any significant relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of these continuing pharmacy education programs. Any resident or fellow presentation is reviewed by a content specialist preceptor. These disclosures will be available at the program.
CPE Monitor: When registering for this program, you will be asked to provide your NABP eProfile ID# and Birthday (MMDD) when registering for this meeting. This information is required by any participants seeking CPE credit.
Visit www.ichpnet.org/cpemonitor/ for information about CPE Monitor and how to obtain your NABP ID.
PTCB requires CPhTs to submit 20 hours of pharmacy technician-specific (‘T-specific’) continuing pharmacy education (CPE) to qualify for recertification. Please advise all pharmacy technicians at your site of this change. As an ACPE accredited provider, ICHP will continue to include Technician specific programming in most if not all of our CPE programming.
